Fetal Aortic Stenosis: Balloon Valvuloplasty in Modern Practice
When clinicians talk about congenital heart disease presenting in utero, critical aortic stenosis stands out as one of the few lesions where action before birth can change the trajectory of a pregnancy. Once a uniformly fatal or severely disabling condition, evolving severe stenosis of the fetal aortic valve is now addressed through a procedure that travels through the mother's abdomen, across the uterine wall, and into the tiny chambers of a still-developing heart. The technique, balloon valvuloplasty for aortic stenosis, has moved from a handful of pioneering European and North American centres into mainstream perinatology discussions, including those held within the perinatal societies that serve our region, where the FAOPS 2020 portal gathered the community before the Tokyo congress was postponed.
The logic of the intervention rests on a familiar perinatal principle: obstruction that would otherwise remodel the heart in harmful ways can be relieved early enough to let the left ventricle grow, recover, and prepare for postnatal circulation. The procedure itself is technically demanding, requires a multidisciplinary team, and is not universally offered. For Australian families whose fetus receives a diagnosis of evolving hypoplastic left heart syndrome driven by severe aortic stenosis, the question of whether to attempt fetal cardiac intervention now shapes counselling in tertiary fetal medicine units from Sydney to Perth.
The pathophysiology of evolving aortic stenosis
In mid-gestation, the fetal aortic valve normally opens freely with each systolic ejection from the left ventricle. When the leaflets become thickened and doming becomes restricted, the ventricle must generate higher pressures to drive blood across the narrowing. Over weeks, that chronic afterload alters myocardial mechanics, and the chamber walls thicken while the cavity itself begins to undergrow. The right ventricle, sensing abnormal flow patterns through the foramen ovale and ductus arteriosus, gradually assumes more of the cardiac output. By the time a third-trimester scan confirms a small left ventricle, the heart has often travelled far down a path toward hypoplastic left heart syndrome.
What makes this process clinically actionable is that it is, for a window of weeks, reversible. Fetuses with severe aortic stenosis but a left ventricle that still measures above a certain length threshold, with retrograde flow in the aortic arch, and with signs of preserved function, may be candidates for relief of the obstruction before the ventricle loses its capacity to recover. Recognising that window is the foundation of any fetal cardiac intervention program.
How fetal cardiac intervention emerged
The first reports of successful in utero balloon dilation of the fetal aortic valve appeared in the early 1990s, when cardiologists in Boston and London demonstrated that a catheter could be advanced through the fetal chest and across the valve without causing irreversible harm. The technique was refined throughout the next two decades, with registries in the United States, Europe, and Brazil gathering outcome data on hundreds of procedures. Those data confirmed two consistent findings: technical success rates rose above eighty percent in experienced hands, and a meaningful proportion of survivors achieved a biventricular circulation after birth rather than the single-ventricle palliation that would otherwise have been inevitable.
The accumulated evidence shifted the conversation from whether fetal aortic valvuloplasty could be performed to how, when, and where it should be offered. International societies began drafting consensus criteria, and collaborative networks emerged to centralise referrals. In our region, fetal medicine specialists increasingly look to the work shared through gatherings such as the FAOPS 2020 scientific program, where perinatal cardiology featured prominently. Broader perinatal topics also appear on such platforms, including neonatal conditions that share the same theme of timely intervention, such as the cholestasis management pathway discussed within the FAOPS educational resources.
Identifying suitable candidates
Careful selection is the single biggest determinant of outcome. The usual entry point is a detailed fetal echocardiogram, performed by a paediatric cardiologist experienced in congenital heart disease, between twenty and twenty-eight weeks of gestation. The scan must confirm severe aortic stenosis with measurable anatomic features, demonstrate a left ventricular length and cavity size above thresholds derived from international registries, and exclude features that predict poor recovery, such as severe mitral regurgitation, very low left ventricular length, or monofocal ventricular dysfunction with no signs of contractile reserve.
Beyond the imaging, the team assesses the broader clinical picture. Maternal health, cervical length, placental location, and accessibility of the fetal chest all influence procedural risk. Counselling extends over several visits and includes discussion of the option of expectant management with planned postnatal single-ventricle palliation, the option of pregnancy termination where legal, and the option of fetal intervention itself. Families in regional and rural Australia often travel long distances for such counselling, with major fetal cardiology hubs in Melbourne, Sydney, Brisbane, and Adelaide serving as referral centres.
The valvuloplasty procedure step by step
On the day of the procedure, the mother is positioned supine with left uterine displacement, and either spinal-epidural anaesthesia or local infiltration with intravenous sedation is administered. Real-time ultrasound guides every movement after that. A thin cannula is introduced through the maternal abdominal wall, the uterine wall, and into the fetal chest, aiming for the left ventricular apex. A guidewire is then advanced across the stenotic aortic valve, and a coronary angioplasty balloon catheter, typically three to four millimetres in diameter, is inflated briefly across the valve leaflets.
The total intracardiac time is short, often under sixty seconds, and the fetal heart is monitored continuously for rhythm disturbances, pericardial effusion, and valve competence immediately after the dilation. A successful procedure produces immediate reduction in the aortic valve gradient, improved antegrade flow across the arch, and visible growth of the left ventricle on follow-up scans over the following weeks. The procedure is technically demanding, and fewer than twenty centres worldwide perform it regularly; procedural volume is a recognised marker of safety.
Outcomes after fetal aortic valvuloplasty
The literature describes several patterns of outcome after successful dilation. The most desirable is a biventricular circulation at birth, with the neonate leaving hospital after either a postnatal valvuloplasty or, less commonly, surgical valvotomy. Registry data suggest that between forty and sixty percent of technically successful procedures result in a biventricular outcome in appropriately selected cases. A second pattern is a partial rescue, in which the left ventricle grows but ultimately proves insufficient, leading to postnatal single-ventricle palliation. A third pattern is procedure-related loss, which remains the most sobering consideration for any team offering the intervention.
Long-term follow-up of survivors shows that the valve and ventricle remain vulnerable throughout childhood, with a substantial proportion requiring repeat balloon valvuloplasty, surgical valvotomy, or eventually valve replacement. Comprehensive surveillance, including annual cardiology review, is therefore essential. In Australia, such follow-up is coordinated through paediatric cardiac services at the Royal Children's Hospital in Melbourne, the Children's Hospital at Westmead in Sydney, and the Queensland Children's Hospital in Brisbane, with outreach clinics supporting families closer to home.
Building teams in Australian centres
Australian fetal medicine practice has long operated within a hub-and-spoke model, with tertiary centres providing intervention and complex diagnostics while regional obstetric units maintain routine antenatal care. For fetal aortic valvuloplasty to be offered equitably, that model must be reinforced. National referral pathways, formalised links with international centres of excellence, and protected time for team training are all required. The Royal Australian and New Zealand College of Obstetricians and Gynaecologists, alongside the Australian and New Zealand Society of Paediatric Cardiology, plays a central role in setting standards and maintaining clinical networks.
Workforce considerations matter as much as equipment. Each procedure needs a fetal cardiologist, an interventional cardiologist trained in fetal access, an obstetric sonologist, a fetal medicine obstetrician, an anaesthetist familiar with maternal-fetal cases, and dedicated nursing support. Maintaining such a roster outside a major capital city is challenging, which is why Australian activity is concentrated in a small number of established programs. Funding models, including support for interstate transfers and accommodation for regional families, also shape access, particularly in a federation where state borders can complicate shared care.
Looking forward in research and training
The next decade is likely to bring refinements in case selection, refinements in catheter technology, and possibly alternative percutaneous or minimally invasive approaches. International registries continue to gather data, and artificial intelligence tools are being explored to predict, from a single echocardiographic dataset, which fetuses will benefit from intervention. There is also growing interest in whether earlier intervention, before severe ventricular remodelling sets in, could improve the proportion of biventricular outcomes across all participating programs.
For clinicians across Australia and the broader Asia-Pacific region, ongoing education is essential. Educational platforms such as those curated for the FAOPS 2020 program provide a useful complement to hands-on fellowships, and emerging fetal cardiology content continues to share space with adjacent neonatal topics. The principles of safe pleural drainage in the neonate, for instance, are covered in dedicated resources on pneumothorax drainage, reminding practitioners that skill in fetal and neonatal procedures shares a common ethic of careful timing and decisive action.
Practical considerations for teams considering a fetal valvuloplasty service
- Develop a written protocol covering case selection, procedural steps, anaesthesia, and postnatal handover, aligned with international consensus criteria.
- Establish formal referral agreements with regional obstetric units, including standardised echocardiographic reporting templates that capture the markers used in published registries.
- Invest in simulator-based training for the interventional cardiology team, alongside supervised proctoring by an experienced fetal intervention centre before the first independent case.
- Maintain a prospective database of every attempted procedure, with consent for inclusion in international registries, to support both local audit and collaborative research.
- Provide structured psychological support for families throughout decision-making, the procedure itself, and the months of follow-up that follow.
If you are a clinician, sonographer, or trainee with an interest in fetal cardiology, consider visiting the FAOPS 2020 website to explore the educational stories and archived content on neonatal and perinatal care. Sharing knowledge across disciplines and borders remains the most reliable way to improve outcomes for the smallest patients and the families who depend on us.
